Infusion 51a's Press Releases
Our Portfolio Companies' Press Releases
Our Portfolio Companies' Press Releases
Our Portfolio Companies' Press Releases
Vivacitas Oncology Presents its New Neuro-Oncology Advisor, Dr. Andrew Lassman MD, MS, FAAN
WALNUT CREEK, CALIFORNIA, US, December 15, 2021 – Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a privately-held oncology company focused on tough–to–treat cancers, is pleased
Vivacitas Oncology Announces Additions to Leadership Team and Board
Vivacitas Oncology, Inc. is pleased to announce the addition of Mark Suseck as new Director and Chief Executive Officer and Frank D. Heuszel as Director.
Vivacitas Oncology, Inc. and Image Analysis Group to Present on AR-67 Clinical Response Evaluation at the Society for Neuro-oncology Annual Conference
Walnut Creek, CA, USA, and London, UK, November 18, 2021, Vivacitas Oncology, a privately-held oncology company focused on tough–to–treat cancers, and Image Analysis Group (IAG),
Infusion 51a co-founded company Vivacitas Oncology closes $1 million from DSS as it explores going public
DSS Continues to Grow its Healthcare Segment through $1M Investment in Vivacitas Oncology ROCHESTER, N.Y., August 2, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc.
Vivacitas Oncology and IAG Partner to Integrate Novel Imaging Markers in the Development of AR-67 in Recurrent Glioblastoma Patients – IAG
[WALNUT CREEK, CALIFORNIA, US AND LONDON, UK, May 3, 2021] – Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a clinical stage biopharmaceutical company focused on
DSS Expands its Healthcare Segment through Investment in Vivacitas Oncology
DSS Expands its Healthcare Segment through Investment in Vivacitas Oncology ROCHESTER, N.Y., April 08, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the